Regulatory Guidance Horizon Scanner (FDA/EMA/ICH)
Continuously tracks and classifies new guidance changes to reduce missed compliance updates Evidence basis: FDA EMA and ICH have issued multiple AI and adaptive-design updates from 2023 to 2025 indicating a rapidly changing requirement landscape; automation is most defensible as a compliance process accelerator rather than a direct clinical outcome driver
The Problem
“Continuously monitor FDA, EMA, and ICH guidance changes to prevent missed compliance updates”
Organizations face these key challenges:
Guidance updates are distributed across multiple agencies, formats, and publication channels
Manual review of PDFs, web pages, and consultation documents is slow and inconsistent
Teams struggle to determine which updates are relevant to specific products, studies, or functions
Change summaries often lack source traceability and version comparison
Consultation feedback analysis does not scale when comment volumes are high
Patient preference and emerging AI-related guidance require specialized topic tagging and interpretation
No single system of record exists for regulatory horizon scanning decisions and follow-up actions
Impact When Solved
The Shift
Human Does
- •Monitor FDA, EMA, and ICH guidance sources manually
- •Review new publications and identify relevant changes
- •Track updates and owners in spreadsheets
- •Assess compliance impact and decide follow-up actions
Automation
Human Does
- •Validate high-priority guidance changes and confirm relevance
- •Approve compliance actions and escalation decisions
- •Handle ambiguous or conflicting updates across agencies
AI Handles
- •Continuously monitor FDA, EMA, and ICH guidance sources
- •Classify new guidance updates by topic and urgency
- •Flag potentially high-impact changes for review
- •Generate concise update summaries for expert assessment
Operating Intelligence
How it works
AI watches every signal continuously.
Humans investigate what it flags.
False positives train the next watch cycle.
Who is in control at each step
Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.
Step 1
Observe
Step 2
Classify
Step 3
Route
Step 4
Exception Review
Step 5
Record
Step 6
Feedback
AI lead
Autonomous execution
Human lead
Approval, override, feedback
AI observes and classifies continuously. Humans only engage on flagged exceptions. Corrections sharpen future detection.
The Loop
6 steps
Observe
Continuously take in operational signals and events.
Classify
Score, grade, or categorize what is coming in.
Route
Send routine items to the right path or queue.
Exception Review
Humans validate flagged edge cases and adjust standards.
Authority gates · 1
The system must not declare a guidance update applicable to a development program or regulated process without review by regulatory affairs or quality leadership. [S1][S2][S3]
Why this step is human
Exception handling requires contextual reasoning and organizational judgment the model cannot reliably provide.
Record
Store outcomes and create the operating audit trail.
Feedback
Corrections and outcomes improve future performance.
1 operating angles mapped
Operational Depth
Technologies
Technologies commonly used in Regulatory Guidance Horizon Scanner (FDA/EMA/ICH) implementations:
Key Players
Companies actively working on Regulatory Guidance Horizon Scanner (FDA/EMA/ICH) solutions:
Real-World Use Cases
Patient preference evidence generation for drug development and regulatory submissions
Drug makers can run structured studies to learn which treatment benefits and risks patients care about most, then use that evidence when designing medicines and submitting them to regulators.
Regulatory feedback analysis for MHRA radiopharmaceutical guidance consultation
An AI tool could read stakeholder comments on MHRA’s draft radiopharmaceutical guidance, group similar issues, and highlight where people found the guidance confusing or hard to apply.